Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1025620130160030346
Korean Journal of Medical Ethics
2013 Volume.16 No. 3 p.346 ~ p.360
Analysis of the Degree of Cancer Patients¡¯ Awareness on Clinical Trials: A View of Subject¡¯s Protection
Kim Ji-Ye

Yi Seung-Yoon
Lee Hye-Ran
Abstract
This study was designed to assess the degree of cancer patients¡¯ awareness of the nature of clinical trials (CT) and to provide basic information for further research in developing systems of protection for vulnerable patients. Patients diagnosed with cancer and admitted for chemotherapy or receiving outpatient treatment were surveyed. The survey consisted of three parts to gather information on (1) patients¡¯ awareness of the nature of CT in general, (2) patients¡¯ awareness of CT from medical perspec-tives, and (3) the relationship between intent to participate in CT and financial compensation. Eighty-five patients participated in the survey. In the first part, many patients answered that they would partic-ipate in the study lest they be put at a disadvantage for not participating, while others said they would participate because they felt they would receive special treatment. In the second part, scores were lowest in men, the elderly, the unemployed, and those who participated as a result of decisions made by their spouses. In the third part, rewards influenced women more than men, and patients in their 60s expected a greater reward than those in other groups. Most cancer patients may not be sufficiently aware of the nature of CT and may be vulnerable when making decisions by themselves. Therefore, it is necessary for patients to receive more information on CT and for the information to be presented in terms that patients can easily understand. A system for the protection of vulnerable patients may also be needed.
KEYWORD
clinical trial, neoplasms, recognition, human rights
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø